Sanctuary Advisors’s INmune Bio INMB Stock Holding History

Sanctuary Advisors’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,045	Closed	-$102K	–	2442
2024 Q3	$102K	Buy	+21,045	New	+$150K	﹤0.01%	2310

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Sanctuary Advisors's INMB Position: Q4 2024 in Review

Sanctuary Advisors sold out of INmune Bio (INMB) in Q4 2024, closing a stake of 21,045 shares — an estimated $102K sold.

Sanctuary Advisors first reported a position in INMB in Q3 2024 and held it in 1 quarter. The position peaked at $102K in Q3 2024. 73 funds tracked by Wall St. Rank hold INMB as of Q4 2024.

Sanctuary Advisors reported no remaining INmune Bio position as of Q4 2024 after selling out during the quarter.
Sanctuary Advisors sold 21,045 INmune Bio shares in Q4 2024, an estimated $102K.
Sanctuary Advisors first reported a position in INmune Bio in Q3 2024 and held it in 1 quarter.
Sanctuary Advisors's INmune Bio position peaked at $102K in Q3 2024.
73 funds tracked by Wall St. Rank held INmune Bio as of Q4 2024.

Based on Sanctuary Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.